Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.

Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB.

Lancet. 1999 Sep 4;354(9181):803-9.

PMID:
10485721
2.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
3.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
4.

A review of studies assessing the costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-Saharan Africa.

Scotland GS, van Teijlingen ER, van der Pol M, Smith WC.

AIDS. 2003 May 2;17(7):1045-52. Review.

PMID:
12700455
5.

Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.

Creese A, Floyd K, Alban A, Guinness L.

Lancet. 2002 May 11;359(9318):1635-43. Review. Erratum in: Lancet 2002 Sep 14;360(9336):880.

PMID:
12020523
6.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
7.

Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?

Verguet S, Stalcup M, Walsh JA.

Sex Transm Infect. 2013 Dec;89(8):628-34. doi: 10.1136/sextrans-2012-050891. Epub 2013 Aug 2. Review.

PMID:
23912819
8.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Brocklehurst P, Volmink J.

Cochrane Database Syst Rev. 2002;(2):CD003510. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD003510.

PMID:
12076484
9.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Brocklehurst P, Volmink J.

Cochrane Database Syst Rev. 2002;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD003510.

PMID:
11869666
10.

Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.

Ngambi PG, Kalungia AC, Law MR, Kalemeera F, Truter I, Godman B, Munkombwe D.

Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):459-467. doi: 10.1080/14737167.2017.1364161. Epub 2017 Aug 11. Review.

PMID:
28770641
11.

International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.

Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.

Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S42-55. Review.

PMID:
17825650
12.

Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.

Colombini M, Stöckl H, Watts C, Zimmerman C, Agamasu E, Mayhew SH.

AIDS Care. 2014;26(7):914-26. doi: 10.1080/09540121.2013.869539. Epub 2013 Dec 20. Review.

PMID:
24354642
13.

Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?

De Nardo P, Gentilotti E, Nguhuni B, Vairo F, Chaula Z, Nicastri E, Ippolito G.

Expert Rev Anti Infect Ther. 2016;14(1):19-27. doi: 10.1586/14787210.2016.1116383. Epub 2015 Dec 3. Review.

PMID:
26559430
14.

Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.

Samuel R, Paredes R, Parboosing R, Moodley P, Gordon M.

AIDS Rev. 2014 Oct-Dec;16(4):187-98. Review.

PMID:
25300623
15.

Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.

Tudor Car L, van-Velthoven MH, Brusamento S, Elmoniry H, Car J, Majeed A, Atun R.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD008741. doi: 10.1002/14651858.CD008741.pub2. Review.

PMID:
21678382
16.

Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.

Bardsley-Elliot A, Perry CM.

Paediatr Drugs. 2000 Sep-Oct;2(5):373-407. Review.

PMID:
11022799
17.

Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses.

Karnon J, Orji N.

Health Policy Plan. 2016 Oct;31(8):1133-41. doi: 10.1093/heapol/czw025. Epub 2016 Mar 26. Review.

PMID:
27016949
18.

Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.

Paredes R, Marconi VC, Lockman S, Abrams EJ, Kuhn L.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S93-100. doi: 10.1093/infdis/jit110. Review.

19.

Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?

McConnell MS, Stringer JS, Kourtis AP, Weidle PJ, Eshleman SH.

Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S56-63. Review.

PMID:
17825651
20.

Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa.

le Roux SM, Abrams EJ, Nguyen K, Myer L.

Trop Med Int Health. 2016 Jul;21(7):829-45. doi: 10.1111/tmi.12716. Epub 2016 May 20. Review.

Supplemental Content

Support Center